Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
The first night of the Democratic National Convention (DNC) could have investors eyeing sectors like healthcare and automotive ...
According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 bill...
Wells Fargo Investment Institute has a 4600-4800 year-end 2024 target for the S&P 500 Index and 2000-2200 for the MSCI EAFE...
While the markets are focussing on the October jobs report missing expectations, here's a missing piece that may prove them...
A proposed regulatory shift has injected uncertainty into the laboratory-testing market just as startups advance various tests ...
Goldman Sachs compiled research suggesting the global pharmaceutical sector has approximately $700 billion available for M&...
The National Institutes of Health (NIH) has halted a trial evaluating the safety and effectiveness<
-Reuters
